Inj., plazomicin, 5 mg
Products billed under this code include Zemdri.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Zemdri.
Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Zemdri | Cipla USA, Inc. | 69097-0820-96 | 1000 | $3,519.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $3.519 | $0.00 | 5 MG | Inj., plazomicin, 5 mg | v1, posted September 17, 2026 |
| 3Q26 | $3.519 | +$0.011 | 5 MG | Inj., plazomicin, 5 mg | v1, posted September 15, 2026 |
| 2Q26 | $3.508 | −$0.002 | 5 MG | Inj., plazomicin, 5 mg | v1, posted September 15, 2026 |
| 1Q26 | $3.51 | +$0.006 | 5 MG | Inj., plazomicin, 5 mg | v1, posted September 15, 2026 |
| 4Q25 | $3.504 | −$0.07 | 5 MG | Inj., plazomicin, 5 mg | v1, posted September 8, 2026 |
| 3Q25 | $3.574 | $0.00 | 5 MG | Inj., plazomicin, 5 mg | v1, posted March 10, 2026 |
| 2Q25 | $3.574 | $0.00 | 5 MG | Inj., plazomicin, 5 mg | v1, posted March 10, 2026 |
| 1Q25 | $3.574 | −$0.019 | 5 MG | Inj., plazomicin, 5 mg | v1, posted December 19, 2025 |
| 4Q24 | $3.593 | $0.00 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 11, 2025 |
| 3Q24 | $3.593 | −$0.005 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 11, 2025 |
| 2Q24 | $3.598 | −$0.001 | 5 MG | Inj., plazomicin, 5 mg | v1, posted March 11, 2025 |
| 1Q24 | $3.599 | +$0.021 | 5 MG | Inj., plazomicin, 5 mg | v1, posted December 19, 2024 |
| 4Q23 | $3.578 | +$0.222 | 5 MG | Inj., plazomicin, 5 mg | v1, posted October 10, 2024 |
| 3Q23 | $3.356 | −$0.028 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 5, 2024 |
| 2Q23 | $3.384 | −$0.054 | 5 MG | Inj., plazomicin, 5 mg | v1, posted February 23, 2024 |
| 1Q23 | $3.438 | +$0.212 | 5 MG | Inj., plazomicin, 5 mg | v1, posted December 6, 2023 |
| 4Q22 | $3.226 | +$0.098 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 22, 2023 |
| 3Q22 | $3.128 | −$0.015 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 9, 2023 |
| 2Q22 | $3.143 | +$0.044 | 5 MG | Inj., plazomicin, 5 mg | v1, posted December 14, 2022 |
| 1Q22 | $3.099 | +$0.052 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 8, 2022 |
| 4Q21 | $3.047 | +$0.002 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 2, 2022 |
| 3Q21 | $3.045 | −$0.135 | 5 MG | Inj., plazomicin, 5 mg | v1, posted June 2, 2022 |
| 2Q21 | $3.18 | +$0.108 | 5 MG | Inj., plazomicin, 5 mg | v1, posted March 1, 2022 |
| 1Q21 | $3.072 | – | 5 MG | Inj., plazomicin, 5 mg | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.